03 Dec 2019
Ardelyx Inc's experimental drug has shown promise in a late-stage study as a standalone therapy to reduce elevated blood phosphate levels in patients with chronic kidney disease (CKD), the drugmaker said on Tuesday.
14 Nov 2019
Nov 14 The U.S. Food and Drug Administration on
Thursday approved BeiGene Ltd's lymphoma
treatment, validating the China-based drugmaker's strategy of
largely using data from trials held outside the United States to
file for approval.
14 Nov 2019
Independent experts on an FDA advisory panel on Wednesday voted against the use of an already approved diabetes drug from Eli Lilly and Co and Boehringer Ingelheim as an add-on to insulin therapy in patients with type 1 diabetes.
12 Nov 2019
Shares in Solid Biosciences Inc plunged 71% on Tuesday after a trial testing its gene therapy for a muscle-wasting disorder was halted for the second time in less than two years.
28 Oct 2019
A newly approved three-drug treatment for tuberculosis will be available in 150 countries including India and South Africa, priced at $1,040 for a complete regimen, more than twice the cost proposed in the past by advocacy groups for other treatments.
28 Oct 2019
Oct 28 A newly-approved three-drug treatment for
tuberculosis will be available in 150 countries including India
and South Africa, priced at $1,040 for a complete regimen, more
than twice the cost proposed in the past by advocacy groups for
other treatments.
25 Oct 2019
Four major U.S. retailers, including Walmart and Target Corp , are removing all 22-ounce bottles of Johnson & Johnson's baby powder from their stores, following the healthcare conglomerate's recall last week of some bottles due to possible asbestos contamination. | Video
21 Oct 2019
Vertex Pharmaceuticals Inc has priced its three-drug combination for cystic fibrosis (CF) at $311,503 per year, after winning early U.S. approval on Monday.